| Application no. and date | 15816598.5 (espacenet) (Federated) (European Patent Register), 20151201 | | Patent/reg. no. and date | DK/EP 3227454, 20200129 | | Publication date | 20171011 | | Priority no. and date | US 201462085759 P, 20141201 | | EP pub. no. and date |
EP 3227454 20171011 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | 1545044 | | Inventor | LEISKE, Daniel R., 305 SE Bush Street
Issaquah, Washington 98027, US,
TRENTALANGE, Michael T., 950 20th Avenue East
Seattle, Washington 98112, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , C07K 14/00 (2006.01) , C07K 16/00 (2006.01) , C07K 16/24 (2006.01) , C12P 21/00 (2006.01) , C12P 21/02 (2006.01) | | Title | FREMGANGSMÅDE TIL MANIPULERING AF NIVEAUET AF GLYCANINDHOLD PÅ ET GLYCOPROTEIN | | Int. application no. | US2015063271 | | Int. publication no. | WO2016089919 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
